BioCentury
ARTICLE | Politics & Policy

TB Alliance partners with Medicines Patent Pool

April 21, 2016 1:17 AM UTC

The Global Alliance for TB Drug Development and the Medicines Patent Pool (MPP) will collaborate to share IP and form licensing strategies for future tuberculosis treatments developed by the TB Alliance. The partners aim to provide affordable TB treatments in countries with a high incidence of the disease.

The partners said they also intend to evaluate licensing opportunities for TB compounds already in development, and to improve pediatric access to existing medicines. They plan to share patent status, sales information and epidemiological data, and intend to consult with public health organizations to develop TB drug market forecasts. ...